Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Genetics

Free Subscription Articles published in Cancer Retrieve available abstracts of 32 articles: HTML format

Single Articles

March 2024
1. KOTECHA RR, Knezevic A, Arora K, Bandlamudi C, et al
   Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
   Cancer. 2024;130:692-701.
   PubMed     Abstract available
   
   
   February 2024
2. YEKU OO
   Racial disparities and referral for genetic counseling.
   Cancer. 2024;130:505-506.
   PubMed    
   
   
   November 2023
3. HOWARD SHARP KM, Nichols KE
   Insights into parent and adolescent patient understanding of genomic sequencing.
   Cancer. 2023;129:3519-3521.
   PubMed    
   
   
   October 2023
4. NIERENGARTEN MB
   Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities.
   Cancer. 2023;129:3192.
   PubMed    
   
   
   September 2023
5. DASH C, Mills MG, Jones TD, Nwabukwu IA, et al
   Design and pilot implementation of the Achieving Cancer Equity through Identification, Testing, and Screening (ACE-ITS) program in an urban underresourced population.
   Cancer. 2023;129.
   PubMed     Abstract available
   
   
   June 2023
6. MOORADIAN MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al
   Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
   Cancer. 2023;129:1904-1918.
   PubMed     Abstract available
   
   
   April 2023
7. NIERENGARTEN MB
   Helping oncologists utilize genomics in cancer care: An updated definition of the uses of genetic biomarkers in cancer diagnosis and care can make a difference in how physicians understand their use in the clinic.: An updated definition of the uses of
   Cancer. 2023;129:1140-1141.
   PubMed    
   
   
   March 2023
8. OHYAMA H, Hirotsu Y, Amemiya K, Miura Y, et al
   Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile.
   Cancer. 2023 Mar 18. doi: 10.1002/cncr.34717.
   PubMed     Abstract available
   
   
   
9. WILLIAM WN JR, Zhang J, Zhao X, Parra ER, et al
   Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
   Cancer. 2023;129:714-727.
   PubMed     Abstract available
   
   
   February 2023
10. GUPTA DG, Varma N, Kumar A, Naseem S, et al
    Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients.
    Cancer. 2023 Feb 3. doi: 10.1002/cncr.34665.
    PubMed     Abstract available
    
    
    January 2023
11. WIN TS, Tsao H
    Keratinocytic skin cancers-Update on the molecular biology.
    Cancer. 2023 Jan 16. doi: 10.1002/cncr.34635.
    PubMed     Abstract available
    
    
    December 2022
12. FREY MK, Ahsan MD, Badiner N, Lin J, et al
    What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
    Cancer. 2022;128:4241-4250.
    PubMed     Abstract available
    
    
    May 2022
13. LOKE J, Labopin M, Craddock C, Cornelissen JJ, et al
    Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemia.
    Cancer. 2022 May 25. doi: 10.1002/cncr.34268.
    PubMed     Abstract available
    
    
    April 2022
14. REIZINE NM, Danahey K, Truong TM, George D, et al
    Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Cancer. 2022;128:1649-1657.
    PubMed     Abstract available
    
    
    
15. STADLER WM, Hlubocky FJ, Hathaway F
    Knowledge and distress in complex cancer care.
    Cancer. 2022;128:1359-1360.
    PubMed    
    
    
    February 2022
16. OSAKO T, Matsuura M, Yotsumoto D, Takayama S, et al
    A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
    Cancer. 2022 Feb 28. doi: 10.1002/cncr.34144.
    PubMed     Abstract available
    
    
    
17. KISIEL JB, Papadopoulos N, Liu MC, Crosby D, et al
    Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.
    Cancer. 2022;128 Suppl 4:861-874.
    PubMed     Abstract available
    
    
    
18. CROWDER SL, Hoogland AI, Welniak TL, LaFranchise EA, et al
    Metagenomics and chemotherapy-induced nausea: A roadmap for future research.
    Cancer. 2022;128:461-470.
    PubMed     Abstract available
    
    
    January 2022
19. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available
    
    
    October 2021
20. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available
    
    
    August 2021
21. HENDERSON V, Ganschow P, Wang C, Hoskins KF, et al
    Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
    Cancer. 2021 Aug 23. doi: 10.1002/cncr.33867.
    PubMed    
    
    
    
22. NECCHI A, Cucchiara V, Grivas P, Bratslavsky G, et al
    Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33865.
    PubMed     Abstract available
    
    
    
23. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available
    
    
    April 2021
24. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    PubMed     Abstract available
    
    
    
25. CULVER JO, Ricker CN, Bonner J, Kidd J, et al
    Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    Cancer. 2021;127:1275-1285.
    PubMed     Abstract available
    
    
    
26. PARK S, Olsen S, Ku BM, Lee MS, et al
    High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33571.
    PubMed     Abstract available
    
    
    
27. PRINTZ C
    First person profile: Matthew L. Meyerson, MD, PhD: Pioneering scientist leads key discoveries in cancer genomics.
    Cancer. 2021;127:991-993.
    PubMed    
    
    
    
28. HENDERSON V, Chukwudozie IB, Comer-Hagans D, Coffey V, et al
    Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525.
    PubMed     Abstract available
    
    
    October 2020
29. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed     Abstract available
    
    
    June 2020
30. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    PubMed     Abstract available
    
    
    
31. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.
    PubMed    
    
    
    March 2020
32. PASSARO A, Malapelle U, Attili I, de Marinis F, et al
    Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32810.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.